Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (211-220 of 1,279) with videos related to

Pageof 128
Sort By:
Annals of Hepatology|April 21, 2017
Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis BItziar Oyagüez, María Buti, Max Brosa, et al.
Journal of Medical Virology|January 1, 1986
Serological diagnosis of acute delta hepatitisM Buti, R Esteban, R Jardí, et al.
British Dental Journal|February 27, 2026
The influence of oral health on sports performance: an interdisciplinary perspectiveKarsten Hollander, Inbar Eshkol-Yogev, Astrid Zech, et al.
Hepatology (Baltimore, Md.)|February 1, 1990
The presence of anti-HCV antibodies in the serum of patients with chronic active hepatitis and antinuclear antibodiesM Roget, M Buti, J I Esteban, et al.
International Urology and Nephrology|November 8, 2007
De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infectionJose L Tovar, Maria Buti, Alfonso Segarra, et al.
Gastroenterology|January 1, 1987
Severe hepatic failure after ARA-A-prednisolone for chronic type B hepatitisM Buti, R Esteban, J I Esteban, et al.
American Journal of Dentistry|February 25, 2015
In vitro comparison of bonding effectiveness of different adhesive strategiesDaniele Scaminaci Russo, Felicita Pierleoni, Jacopo Buti, et al.
Medicina Clinica|June 8, 1985
[Acalculous cholecystitis and drug addiction]M Buti, R Esteban, D G Sureda, et al.
Expert Review of Anti-Infective Therapy|October 24, 2025
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis deltaJuan Carlos Ruiz-Cobo, Adriana Palom, Mar Riveiro-Barciela, et al.
Autoimmunity Reviews|September 25, 2023
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditionsMaria Giovanna Danieli, Eleonora Antonelli, Stefania Auria, et al.
Pageof 128

Showing results (211-220 of 1,279) with videos related to

Sort By:
Pageof 128
Annals of Hepatology|April 21, 2017
Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis BItziar Oyagüez, María Buti, Max Brosa, et al.
Journal of Medical Virology|January 1, 1986
Serological diagnosis of acute delta hepatitisM Buti, R Esteban, R Jardí, et al.
British Dental Journal|February 27, 2026
The influence of oral health on sports performance: an interdisciplinary perspectiveKarsten Hollander, Inbar Eshkol-Yogev, Astrid Zech, et al.
Hepatology (Baltimore, Md.)|February 1, 1990
The presence of anti-HCV antibodies in the serum of patients with chronic active hepatitis and antinuclear antibodiesM Roget, M Buti, J I Esteban, et al.
International Urology and Nephrology|November 8, 2007
De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infectionJose L Tovar, Maria Buti, Alfonso Segarra, et al.
Gastroenterology|January 1, 1987
Severe hepatic failure after ARA-A-prednisolone for chronic type B hepatitisM Buti, R Esteban, J I Esteban, et al.
American Journal of Dentistry|February 25, 2015
In vitro comparison of bonding effectiveness of different adhesive strategiesDaniele Scaminaci Russo, Felicita Pierleoni, Jacopo Buti, et al.
Medicina Clinica|June 8, 1985
[Acalculous cholecystitis and drug addiction]M Buti, R Esteban, D G Sureda, et al.
Expert Review of Anti-Infective Therapy|October 24, 2025
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis deltaJuan Carlos Ruiz-Cobo, Adriana Palom, Mar Riveiro-Barciela, et al.
Autoimmunity Reviews|September 25, 2023
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditionsMaria Giovanna Danieli, Eleonora Antonelli, Stefania Auria, et al.
Pageof 128